EUVIMEDEUVIMED entdecken
Fallbericht

Complete Pathological Response and Severe Hypothyroidism under Pembrolizumab in Triple-Negative Breast Cancer: Between Triumph and Toxicity – A Case Report.

Batna Journal of Medical Sciences (BJMS) · 01.06.2026 · 13 (6)

DOI: 10.48087/bjms.2026.130618 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Batna Journal of Medical Sciences (BJMS), online erschienen am 01.06.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Complete Pathological Response and Severe Hypothyroidism under Pembrolizumab in Triple-Negative Breast Cancer: Between Triumph and Toxicity – A Case Report. Batna Journal of Medical Sciences (BJMS), 13(6). https://doi.org/10.48087/bjms.2026.130618

Vancouver

Complete Pathological Response and Severe Hypothyroidism under Pembrolizumab in Triple-Negative Breast Cancer: Between Triumph and Toxicity – A Case Report. Batna Journal of Medical Sciences (BJMS). 2026;13(6). doi:10.48087/bjms.2026.130618

BibTeX
@article{euvimed2026,
  title = {Complete Pathological Response and Severe Hypothyroidism under Pembrolizumab in Triple-Negative Breast Cancer: Between Triumph and Toxicity – A Case Report},
  journal = {Batna Journal of Medical Sciences (BJMS)},
  year = {2026},
  volume = {13},
  number = {6},
  doi = {10.48087/bjms.2026.130618}
}
Kostenlos starten →